Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
Back to Search Results

Connection

Search Results to Marc Peter Bonaca

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Bonaca, Marc

Item TypeName
Concept Fibrinolytic Agents
Academic Article Outcomes in Stable Patients With Previous Atherothrombotic Events Receiving Vorapaxar Who Experience a New Acute Coronary Event (from TRA2?P-TIMI 50).
Academic Article Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial.
Academic Article Antithrombotic Therapy and Major?Adverse Limb Events in Peripheral?Artery?Disease: A Step Forward.
Academic Article Antithrombotic Therapy in Patients With Peripheral Artery Disease.
Academic Article Polyvascular disease and risk: When two is not better than one.
Academic Article Appropriate secondary prevention and clinical outcomes after acute myocardial infarction according to atherothrombotic risk stratification: The FAST-MI 2010 registry.
Academic Article Tackling Elevated Risk in PAD: Focus on Antithrombotic and Lipid Therapy for PAD.
Academic Article Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2?P-TIMI 50 trial.
Academic Article Antithrombotic strategies for patients with coronary and lower extremity peripheral artery diseases: a narrative review.
Academic Article Contemporary Review of Antithrombotic Therapy in Peripheral Artery Disease.
Academic Article Contemporary Medical Management of Peripheral Artery Disease.
Academic Article Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials.
Academic Article Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled Trials.

Search Criteria
  • Fibrinolytic Agents

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)